
263: Biogen's messy board, Laronde's data problem, & the downside of a boom
The Readout Loud
00:00
The Boom in VC Backed Biotech
Meg: What does this kind of say about this boom in VC backed biotech, particularly for companies at such early stages of science? Alice: At the time that this company was getting started, you know, biotech was really on the upturn. Meg: I would hope that the industry at large is thinking about how biotech companies are structured and formed.
Transcript
Play full episode